| 1 |
33717143 | Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function. | 2021 |
2 |
| 2 |
33574760 | Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials. | 2020 |
1 |
| 3 |
30696721 | Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study. | 2019 Aug |
1 |
| 4 |
30036377 | BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors. | 2018 |
1 |
| 5 |
28073847 | Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors. | 2017 Feb 15 |
1 |
| 6 |
27573426 | AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies. | 2016 Nov |
3 |